 , Agents Causing Muscle Toxicity , Anti-HIV Agents , Anti-Infective Agents , Anti-Retroviral Agents , Antiinfectives for Systemic Use , Antiviral Agents , Antivirals for Systemic Use , Antivirals used in combination for the treatment of HIV infections , BCRP/ABCG2 Substrates , Deoxycytidine , Deoxyribonucleosides , Dideoxynucleosides , Direct Acting Antivirals , Drugs that are Mainly Renally Excreted , Enzyme Inhibitors , Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor , Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor , Nucleic Acid Synthesis Inhibitors , Nucleic Acids, Nucleotides, and Nucleosides , Nucleoside and Nucleotide Reverse Transcriptase Inhibitors , Nucleoside Reverse Transcriptase Inhibitors , Nucleosides , OAT1/SLC22A6 Substrates , OCT1 substrates , OCT2 Substrates , P-glycoprotein substrates , Pyrimidine Nucleosides , Pyrimidines , Reverse Transcriptase Inhibitors